Citation Impact
Citing Papers
A diagnostic score for the irritable bowel syndrome
1984
Functional bowel disorders and functional abdominal pain
1999 Standout
The Effect of 3–Palmitoyl–(+)–Catechin on Kupffer Cells in Guinea Pig Liver
1985
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
2000 Standout
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Liver fibrosis
2005 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
2012 StandoutNature
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
1988 Standout
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
Nonalcoholic Fatty Liver Disease
2002 Standout
Branched-chain amino acids and ammonia metabolism in liver disease: Therapeutic implications
2013
Treatment of Hepatic Encephalopathy
1997
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Irritable bowel syndrome in general practice: prevalence, characteristics, and referral
2000 Standout
NONALCOHOLIC STEATOHEPATITIS
1996
Porphyrias
2010 Standout
Vascular disorders of the liver # †
2008 Standout
Ursodeoxycholic Acid or Clofibrate in the Treatment of Non–Alcohol–Induced Steatohepatitis: A Pilot Study
1996
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
2009 Standout
Irritable bowel syndrome
2016 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
ALCOHOL AND PORPHYRIN METABOLISM
2000
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Non-alcoholic fatty liver disease
2021 Standout
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
2005 Standout
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
A 5‐decade analysis of 13,715 carcinoid tumors
2003 Standout
Cachexia in liver cirrhosis
2002
Auditory P300 event‐related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: A follow‐up study
2001
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
1989 StandoutNobel
Global burden of liver disease: 2023 update
2023 Standout
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
1999 Standout
Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV)
1990
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆
1999 Standout
The utility of radiological imaging in nonalcoholic fatty liver disease
2002 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
2001 Standout
Enzyme induction in the cytochrome P-450 system
1990 Standout
Branched-Chain Amino Acid Enriched Supplements as Therapy for Liver Disease
2006
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Nutritional support in patients with chronic liver disease
2006
Oral Branched-Chain Amino Acids Have a Beneficial Effect on Manifestations of Hepatic Encephalopathy in a Systematic Review with Meta-Analyses of Randomized Controlled Trials
2013
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Factors which Influence the Incidence and Course of Peptic Ulcer
1988
Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations
2004
A Patient Questionnaire to Identify Bowel Disease
1989 Standout
Risks of Chronicity Following Acute Hepatitis B Virus Infection: A Review
1995
Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial
2003
Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells
1992 StandoutNobel
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
2005 Standout
Nonalcoholic Steatohepatitis
1980 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Primary Myeloproliferative Disorder and Hepatic Vein Thrombosis
1985
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Arterial Changes in the Lungs in Cirrhosis of the Liver — Lung Spider Nevi
1966 Standout
Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease
1991 StandoutNobel
Nonalcoholic Fatty Liver Disease
2001 Standout
The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition.
2011
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
The antioxidant and free radical scavenging activities of processed cowpea (Vigna unguiculata (L.) Walp.) seed extracts
2006 Standout
Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features
1983
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Alterations in pentobarbital pharmacokinetics in response to parenteral and enteral alimentation in the rat
1980
The aetiology and management of ascites in patients with hepatic cirrhosis: A review
1963
Transection of the oesophagus for bleeding oesophageal varices
1973 Standout
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
2021
The Demonstration of Porta-Pulmonary Anastomoses in Portal Cirrhosis with the Use of Radioactive Krypton (Kr85)
1961
A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease.
1984
Cianidanol and its metabolites bind tightly to red cells and are responsible for the production of auto‐ and/or drug‐dependent antibodies against these cells
1987
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Role of Nutrition in the Management of Hepatic Encephalopathy in End-Stage Liver Failure
2010
Fatty Liver Disease in Morbid Obesity
1987
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†
1981 Standout
Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double‐blinded multicentre trial
2013
Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV
1993 StandoutNobel
Quantitation of portasystemic shunting from the splenic and mesenteric beds in alcoholic liver disease
1972
Pitressin-induced myocardial injury and depression in a young woman
1971
Nonalcoholic Fatty Liver Disease
2015 Standout
Bio-Functional Legumes with Nutraceutical, Pharmaceutical, and Industrial Uses
2003
Fatty liver: Biochemical and clinical considerations
1975
Human cytochromes P-450
1984
Works of W Dölle being referenced
Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids
1993
MEASUREMENT OF BLOOD FLOW IN THE COLLATERAL VESSELS OF THE PORTAL VEIN; PRELIMINARY RESULTS OF A NEW METHOD
1960
Monooxygenase enzyme activity in alcoholics with varying degrees of liver damage.
1979
Five-year follow-up study of patients with nonalcoholic and nondiabetic fatty liver.
1974
Cimetidin in der stationären Behandlung des peptischen Ulkus. I. Wirkung auf die Heilung des Ulcus duodeni*
1978
SERUM INHIBITORY FACTORS (SIF) ARE OF PROGNOSTIC VALUE IN ACUTE VIRAL HEPATITIS
1985
[Irritable colon: the most frequent functional disorder of the gastrointestinal tract].
1980
[Influence of diet, glycine and alcohol on porphyrinuria in chronic hepatitic porphyria].
1971
(+)-Cyanidanol-3 in the Treatment of Acute Viral Hepatitis: A Randomized Controlled Trial
1984
Drug metabolizing enzymes in human small intestinal biopsies: Influence of exocrine pancreatic function
1978
Effect of Pitressin on the Splanchnic Circulation in Man
1961
Epidemiologie und Klinik der Non-A-Non-B-Hepatitis: Eine retrospektive Studie aus den Jahren 1970-1976*
2008
Budd-Chiari-Syndrom nach Einnahme eines Ovulationshemmers
1972